| Carl A Kaplan, MD | |
|
3800 W 203rd St Ste 202, Olympia Fields, IL 60461-1185 | |
| (708) 679-2660 | |
| (708) 503-3860 |
| Full Name | Carl A Kaplan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 3800 W 203rd St Ste 202, Olympia Fields, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588751382 | NPI | - | NPPES |
| 209678804 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 114228 (Missouri) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 036130356 (Illinois) | Primary |
| Entity Name | Pittsburgh Critical Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497703680 PECOS PAC ID: 1153223144 Enrollment ID: O20180622001862 |
News Archive
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At a press conference held today at The Endocrine Society's 91st Annual Meeting in Washington, D.C., Nelly Mauras, M.D., Division Chief of Endocrinology at Nemours Children's Clinic in Jacksonville, announced the results of a four year study with findings that show childhood obesity increases early signs of cardiovascular disease. Dr. Mauras' study was chosen for distinction among 5,000 abstracts that were submitted to the national conference.
Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
A surgical team from the University of Central Florida College of Medicine and Arnold Palmer Hospital for Children, Orlando, has presented findings from the first study to demonstrate that the way a ventricular assist device (VAD) is implanted can have an impact on whether or not a patient may have a stroke while the device is in use.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carl A Kaplan, MD 3691 Rutger St., Provider Enrollment, St. Louis, MO 63110 Ph: (314) 977-6828 | Carl A Kaplan, MD 3800 W 203rd St Ste 202, Olympia Fields, IL 60461-1185 Ph: (708) 679-2660 |
News Archive
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At a press conference held today at The Endocrine Society's 91st Annual Meeting in Washington, D.C., Nelly Mauras, M.D., Division Chief of Endocrinology at Nemours Children's Clinic in Jacksonville, announced the results of a four year study with findings that show childhood obesity increases early signs of cardiovascular disease. Dr. Mauras' study was chosen for distinction among 5,000 abstracts that were submitted to the national conference.
Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
A surgical team from the University of Central Florida College of Medicine and Arnold Palmer Hospital for Children, Orlando, has presented findings from the first study to demonstrate that the way a ventricular assist device (VAD) is implanted can have an impact on whether or not a patient may have a stroke while the device is in use.
› Verified 6 days ago
Mr. Praneet Satyendra Mylavarapu, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 20201 Crawford Ave, Olympia Fields, IL 60461 Phone: 708-855-7297 Fax: 708-503-3296 | |
Chintan Shah, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20201 Crawford Ave, Olympia Fields, IL 60461 Phone: 708-747-4000 | |
Albara Said, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3302 Vollmer Rd, Olympia Fields, IL 60461 Phone: 708-898-0811 Fax: 708-898-1839 | |
Anand Kumar Gupta, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20201 Crawford Ave, Olympia Fields, IL 60461 Phone: 708-679-2160 Fax: 708-679-2161 | |
Dr. Matthew L Kamin, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 W 203rd St Ste 204, Olympia Fields, IL 60461 Phone: 708-679-2670 Fax: 708-503-3260 | |
Dr. Edward Joseph Winter, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 20945 Cambridge Ln, Olympia Fields, IL 60461 Phone: 708-747-6929 Fax: 708-747-6929 | |
Dr. Savio G Manatt, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20060 Governors Dr Ste 204, Olympia Fields, IL 60461 Phone: 708-283-8300 Fax: 708-283-9245 |